Lorigerlimab
Product Specifications
CAS Number
2416595-46-3
Target
PD-1/PD-L1
Related Pathways
Immunology/Inflammation, Cell Cycle/Checkpoint, Apoptosis
Bioactivity
Lorigerlimab (MGD019) is a bispecific IgG4 dual-affinity re-targeting (DART) antibody that inhibits PD-1 and CTLA-4 to enhance T-cell responses, currently being investigated for metastatic castration-resistant prostate cancer (mCRPC) [1] [2] [3].
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
More Discoveries
Explore Other Products
Browse additional items from our catalog
